OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ)

CUSIP: G6S41R101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / SHS
Total 13F shares
25,120,022
Share change
+1,079,937
Total reported value
$28,016,566
Put/Call ratio
2%
Price per share
$1.12
Number of holders
34
Value change
+$859,275
Number of buys
14
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q4 2022

As of 31 Dec 2022, OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,120,022 shares. The largest 10 holders included Athyrium Capital Management, LP, Rovida Advisors Inc., AIGH Capital Management LLC, ArrowMark Colorado Holdings LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and BlackRock Inc.. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.